U.S. braces for Omicron, prepares for African country travel ban

By Susan Heavey

WASHINGTON, Nov 28 (Reuters) - U.S. health officials on Sunday said they were preparing for the likely appearance of the new Omicron COVID-19 variant, with restrictions set to begin on Monday against travelers from eight southern African countries.

"Inevitably, it will be here," although no cases have been detected yet, the nation's top infectious disease official, Dr. Anthony Fauci, told ABC News' "This Week."

He added that U.S. health officials would speak with their counterparts in South Africa later on Sunday, saying the flight curbs would give them more time to gather information and weigh possible action.

It "is to get us better prepared, to rev up on the vaccination, to be really ready for something that may not actually be a big deal, but we want to make sure that we're prepared for the worst," he separately told NBC News' "Meet the Press" program.

The new Omicron coronavirus variant, first discovered in South Africa Link and announced in recent days, has already been detected in a growing number of countries.

The United States must do "anything and everything" amid likely cases of the variant but it is "too early to say" whether new lockdowns or mandates are needed, Fauci added on ABC.

Potentially more contagious Link than previous variants, Omicron has sparked worries worldwide, rattling markets and public-health experts who have long warned about ongoing changes to the novel coronavirus amid the race to vaccinate against it.

"It clearly is giving indication that it has the capability of transmitting rapidly. That's the thing that's causing us now to be concerned," Fauci said on "Meet the Press."

Its appearance stateside could threaten to undermine the nation's recovery nearly two years after COVID-19's emergence and further pressure local healthcare systems that have already felt the weight of the recent Delta variant.

Rising cases as colder weather forces more people indoors amid ongoing vaccine hesitancy that has left many people in some U.S. regions unprotected has also forced some hospital systems and U.S. states, including New York, to declare emergencies.

So far, 781,797 people have died in the United States from COVID since early 2020, the most of any country in the world, amid 48,288,375 infections, Reuters data show.

U.S. President Joe Biden, due to arrive back in Washington later on Sunday following the Thanksgiving holiday weekend, has said he is being briefed on the variant.

Meanwhile, the United States is joining other nations in seeking to block transmission by imposing travel restrictions.

Beginning at 12:01 a.m. ET (0500 GMT) on Monday, it will bar entry of nearly all foreign nationals who have been in any of eight southern African countries within the last 14 days and has warned Americans against traveling to those nations.

Still, Delta Air Lines DAL.N and United Airlines UAL.O have said they are not planning any changes to their South Africa-U.S. routes despite the Biden administration's curbs. It was not immediately clear what additional steps travelers may face coming from the region as flights continued over the weekend.

Fauci and other top officials said the sudden burst of cases made Omicron worrisome, but it was not yet clear how current vaccines or therapeutics would be impacted. Vaccine makers Pfizer PFE.N /BioNTech 22UAy.DE and Moderna MRNA.O have said they expect more information soon.

"We need more data there before we can say confidently that this is not a severe version of the virus but we should find that out in the next couple weeks," outgoing National Institutes of Health Director Francis Collins told "Fox News Sunday."

Fauci pressed Americans to continue get COVID-19 vaccines and boosters while experts evaluate Omicron.

"This is a clarion call...(to) get vaccinated," he told NBC.

EXPLAINER-How worried should we be about the Omicron variant? -
Reuters News

Reuters COVID-19 Tracker: United States Link

Additional reporting by Chris Gallagher, Joel Schectman and David Shephardson; Editing by Heather Timmons and Mark Porter

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.